Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
CRISPR Therapeutics is a biotechnology company pioneering gene-edited medicines for serious diseases. The company has one approved therapy and multiple clinical programs targeting hemoglobinopathies, oncology, autoimmune conditions, and in vivo applications.
Parse Score
#69 of 127 in Biopharma Research Platforms and Services
Sources
crisprtx.gcs-web.com shapes more of what AI says about CRISPR Therapeutics than any other source, at 50% of its citations.
livescience.com
The market map
Biopharma Research Platforms and Services →Where AI ranks CRISPR Therapeutics